Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05771480
Title Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) (TOURMALINE)
Acronym TOURMALINE
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Research Site RECRUITING Mobile Alabama 36607 United States Details
Research Site RECRUITING Orange California 92868 United States Details
Research Site RECRUITING Washington District of Columbia 20007 United States Details
Research Site RECRUITING Washington District of Columbia 20010 United States Details
Research Site WITHDRAWN New York New York 10029 United States Details
Research Site RECRUITING Oklahoma City Oklahoma 73142 United States Details
Research Site RECRUITING Portland Oregon 97213 United States Details
Research Site RECRUITING Clichy 92110 France Details
Research Site RECRUITING Dijon 21079 France Details
Research Site RECRUITING Lyon Cedex 03 69437 France Details
Research Site RECRUITING Montpellier Cedex 5 34090 France Details
Research Site RECRUITING Pessac 33604 France Details
Research Site WITHDRAWN Rennes 35042 France Details
Research Site RECRUITING Villejuif 94800 France Details
Research Site RECRUITING Chemnitz 09131 Germany Details
Research Site WITHDRAWN Freudenstadt 72250 Germany Details
Research Site RECRUITING Hannover 30625 Germany Details
Research Site NOT_YET_RECRUITING Muenchen 81377 Germany Details
Research Site RECRUITING Castelfranco Veneto 31033 Italy Details
Research Site RECRUITING Foggia 71122 Italy Details
Research Site RECRUITING Palermo 90146 Italy Details
Research Site RECRUITING Pisa 56126 Italy Details
Research Site RECRUITING Rozzano 20089 Italy Details
Research Site RECRUITING Chuo-ku 104-0045 Japan Details
Research Site RECRUITING Kanazawa-shi 920-8641 Japan Details
Research Site RECRUITING Kashiwa 227-8577 Japan Details
Research Site RECRUITING Kyoto 606-8507 Japan Details
Research Site RECRUITING Osaka 541-8567 Japan Details
Research Site RECRUITING Sendai 980-8574 Japan Details
Research Site RECRUITING Ube 755-8505 Japan Details
Research Site RECRUITING Wakayama 641-8509 Japan Details
Research Site RECRUITING Yokohama 241-8515 Japan Details
Research Site RECRUITING Seoul 03080 Korea, Republic of Details
Research Site RECRUITING Seoul 05505 Korea, Republic of Details
Research Site RECRUITING Seoul 06351 Korea, Republic of Details
Research Site RECRUITING Singapore 169610 Singapore Details
Research Site WITHDRAWN Singapore 258499 Singapore Details
Research Site WITHDRAWN Singapore 329563 Singapore Details
Research Site RECRUITING Barcelona 08035 Spain Details
Research Site NOT_YET_RECRUITING Barcelona 08036 Spain Details
Research Site NOT_YET_RECRUITING Madrid 28007 Spain Details
Research Site RECRUITING Madrid 28027 Spain Details
Research Site RECRUITING Madrid 28040 Spain Details
Research Site RECRUITING Madrid 28041 Spain Details
Research Site RECRUITING Pamplona 31008 Spain Details
Research Site RECRUITING Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field